Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charmaine Yam

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2020
MS, pregnancy and COVID-19Charmaine Yam, Vilija Jokubaitis, Kerstin Hellwig, et al.
BMJ Neurology Open|March 8, 2021
Moyamoya vasculopathy in a young Caucasian woman with significant methamphetamine useTiffany Lin, Charmaine Yam, Su-Ling Lai, et al.
Internal Medicine Journal|February 13, 2019
Interferon-beta in multiple sclerosis causing thrombotic microangiopathyCharmaine Yam, Anthony Fok, Catriona Mclean, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2024
Investigating colour vision and its structural correlates 15 years following a first demyelinating eventCharmaine Yam, Wallace J Brownlee, Ferran Prados Carrasco, et al.
Multiple Sclerosis and Related Disorders|October 6, 2021
UK variance in DMT advice and prescribing in MS and pregnancy: Impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelinesCharmaine Yam, David Rog, Helen Ford, et al.
Annals of Clinical and Translational Neurology|July 16, 2025
Real-World Comparison of High-Efficacy Versus Non-High-Efficacy Therapies in Multiple SclerosisSarmad Al-Araji, Marcello Moccia, Alessia Bianchi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2025
Response to letter to the editor: 'Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis'Ronja Christensen, Amy Jolly, Charmaine Yam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2024
Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosisRonja Christensen, Amy Jolly, Charmaine Yam, et al.
Neurology|February 13, 2026
Performance of the 2024 McDonald Criteria in Patients Under Evaluation for Suspected Multiple SclerosisWallace J Brownlee, Davide Maccarrone, Riccardo Nistri, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosisCharmaine Yam, Daniel Merlo, Jim Stankovich, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2020
MS, pregnancy and COVID-19Charmaine Yam, Vilija Jokubaitis, Kerstin Hellwig, et al.
BMJ Neurology Open|March 8, 2021
Moyamoya vasculopathy in a young Caucasian woman with significant methamphetamine useTiffany Lin, Charmaine Yam, Su-Ling Lai, et al.
Internal Medicine Journal|February 13, 2019
Interferon-beta in multiple sclerosis causing thrombotic microangiopathyCharmaine Yam, Anthony Fok, Catriona Mclean, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2024
Investigating colour vision and its structural correlates 15 years following a first demyelinating eventCharmaine Yam, Wallace J Brownlee, Ferran Prados Carrasco, et al.
Multiple Sclerosis and Related Disorders|October 6, 2021
UK variance in DMT advice and prescribing in MS and pregnancy: Impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelinesCharmaine Yam, David Rog, Helen Ford, et al.
Annals of Clinical and Translational Neurology|July 16, 2025
Real-World Comparison of High-Efficacy Versus Non-High-Efficacy Therapies in Multiple SclerosisSarmad Al-Araji, Marcello Moccia, Alessia Bianchi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2025
Response to letter to the editor: 'Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis'Ronja Christensen, Amy Jolly, Charmaine Yam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2024
Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosisRonja Christensen, Amy Jolly, Charmaine Yam, et al.
Neurology|February 13, 2026
Performance of the 2024 McDonald Criteria in Patients Under Evaluation for Suspected Multiple SclerosisWallace J Brownlee, Davide Maccarrone, Riccardo Nistri, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosisCharmaine Yam, Daniel Merlo, Jim Stankovich, et al.
Pageof 2